Sarepta Therapeutics | 股本和储备

股票价格
18.46
每天变化
0.58 3.22%
每月一次
-12.29%
每年
-82.77%
Q1 预测
17.24


金融业
股票价格
USD
资产
USD 3.49B
现金及等价物
USD 613.08M
销售成本
USD 151.45M
流动资产
USD 2.72B
流动负债
USD 921.43M
债务
USD 1.35B
EBIT
USD -62.88M
EBITDA
USD 126.42M
员工
1.37K
EPS每股收益
USD -0.13
股本和储备
USD 1.32B
销售毛利
USD 247.9M
债务利息支出
USD 7.56M
利息收入
USD 7.14M
贷款资金
USD 1.04B
市值
USD 1.68B
净收入
USD -179.95M
营业费用
USD 462.24M
营业利润
USD -62.88M
普通股股本
USD 104.77M
PE价格收益
USD 27.27
税前利润
USD -194.05M
销售收入
USD 399.4M
销售和管理费用
USD 77.11M
股票
USD 1.08B
贸易债权人
USD 94.02M
应收帐款人
USD 395.74M


股本和储备 更改 日
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Agios Pharmaceuticals USD 1.19B 91.22M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Amgen USD 8.66B 961M 2025-12
BioCryst Pharmaceuticals USD -387.89M 33.7M 2025-09
Biogen USD 18.21B 573.5M 2025-09
BioMarin Pharmaceutical USD 6.06B 29.6M 2025-09
Capricor Therapeutics USD 83.87M 21.11M 2025-09
Daiichi Sankyo JPY 1.71T 57.86B 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Esperion Therapeutics USD -451.36M 17.85M 2025-09
Gilead Sciences USD 22.62B 1.16B 2025-12
Incyte USD 5.17B 516.28M 2025-12
Insmed USD 945.57M 304.16M 2025-09
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Moderna USD 8.65B 680M 2025-12
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
Novavax USD -156.67M 194.3M 2025-09
Pfizer USD 92.8B 4.11B 2025-09
PTC Therapeutics USD -155.76M 50.79M 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sanofi EUR 71.71B 1.55B 2025-12
Sarepta Therapeutics USD 1.32B 37.26M 2025-09
Tectonic Therapeutic USD 267.53M 16.24M 2025-09
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12


Sarepta Therapeutics 股本和储备 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.